Intra- and Interlaboratory Reproducibility of Ultra Performance Liquid Chromatography–Time-of-Flight Mass Spectrometry for Urinary Metabolic Profiling

Abstract

Liquid chromatography coupled to mass spectrometry (LC-MS) is a major platform in metabolic profiling but has not yet been comprehensively assessed as to its repeatability and reproducibility across multiple spectrometers and laboratories. Here we report results of a large interlaboratory reproducibility study of ultra performance (UP) LC-MS of human urine. A total of 14 stable isotope labeled standard compounds were spiked into a pooled human urine sample, which was subject to a 2- to 16-fold dilution series and run by UPLC coupled to time-of-flight MS at three different laboratories all using the same platform. In each lab, identical samples were run in two phases, separated by at least 1 week, to assess between-day reproducibility. Overall, platform reproducibility was good with median mass accuracies below 12 ppm, median retention time drifts of less than 0.73 s and coefficients of variation of intensity of less than 18% across laboratories and ionization modes. We found that the intensity response was highly linear within each run, with a median R(2) of 0.95 and 0.93 in positive and negative ionization modes. Between-day reproducibility was also high with a mean R(2) of 0.93 for a linear relationship between the intensities of ions recorded in the two phases across the laboratories and modes. Most importantly, between-lab reproducibility was excellent with median R(2) values of 0.96 and 0.98 for positive and negative ionization modes, respectively, across all pairs of laboratories. Interestingly, the three laboratories observed different amounts of adduct formation, but this did not appear to be related to reproducibility observed in each laboratory. These studies show that UPLC-MS is fit for the purpose of targeted urinary metabolite analysis but that care must be taken to optimize laboratory systems for quantitative detection due to variable adduct formation over many compound classes.

Metabolomics Benefits from Orbitrap GC–MS—Comparison of Low- and High-Resolution GC–MS

“…In general, studies gauging the benefit of high-versus low-resolution systems are scarce in the field. Some ring trials have been conducted, comparing different laboratories with different mass spectrometers, chromatographic systems, data analysis pipelines, etc., with the aim to validate the hypothesis-generating power of metabolomics as a whole [34,35]. However, those have too many interfering factors to be able to attribute differences found to the resolution of the mass spectrometer used.…”

Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis

“…The metabolome refers to all metabolites present in a given biological system [2]. Metabolomics is an “omics” technology that allows metabolome characterization [3, 4]. Metabolomics is particularly interesting in exploring IEM given their intrinsic with metabolism [5].…”

Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study

“…Such heterogeneity can thus result in discrepancies in the results produced from different places and prevent their generalisation. Several inter-laboratory studies have attempted to validate the accuracy of the metabolomics approach, but these studies all used similar instruments, either NMR of different magnetic fields (Viant et al 2009 ; Ward et al 2010 ) or GC–MS (Allwood et al 2009 ) and LC–MS (Benton et al 2012 ) of the same type. When using tight standardized conditions among the partners these studies showed a high degree of inter-laboratory repeatability.…”